Search results
Showing 2581 to 2595 of 8788 results
Plozasiran for treating familial chylomicronaemia syndrome [ID6593]
In development Reference number: GID-TA11793 Expected publication date: 17 September 2026
In development Reference number: GID-TA11416 Expected publication date: 08 July 2026
Awaiting development Reference number: GID-TA11777 Expected publication date: TBC
Tolebrutinib for treating non-relapsing secondary progressive multiple sclerosis [ID6351]
In development Reference number: GID-TA11333 Expected publication date: TBC
Sodium zirconium cyclosilicate for treating hyperkalaemia (partial review of TA599) [ID6439]
In development Reference number: GID-TA11561 Expected publication date: TBC
Awaiting development Reference number: GID-TA11639 Expected publication date: TBC
In development Reference number: GID-TA11422 Expected publication date: 18 November 2026
PillCam COLON 2 for investigation of the colon through direct visualisation
Deferred Reference number: GID-DG10083
Maralixibat for treating cholestatic pruritus in Alagille syndrome [ID3941]
In development Reference number: GID-TA10832 Expected publication date: TBC
Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)
In development Reference number: GID-NG10216 Expected publication date: 29 July 2026
In development Reference number: GID-TA10046 Expected publication date: 22 November 2017
Inebilizumab for treating generalised myasthenia gravis [ID6587] [TSID12110]
Awaiting development Reference number: GID-TA11667 Expected publication date: TBC
Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092]
In development Reference number: GID-TA10994 Expected publication date: TBC
In development Reference number: GID-TA10575 Expected publication date: TBC
In development Reference number: GID-TA11405 Expected publication date: TBC